Having looked at the Risperdal Augmentation trial [Effects of risperidone augmentation in patients with treatment-resistant depression:…] with an eye to its various permutations as it was published and republished, then looked at its shrinking conclusions[racketeer influenced and corrupt organizations…], I got kind of curious about the study itself. What had they set out to prove […]
In a recent post, I referenced one of Dr. Nemeroff’s review articles, guessing that it was ghostwritten during Janssen’s mid-decade literature Blitzkrieg for Risperdal. As it turns out, this was just one boxcar on a very long train. December 2004: Charles Nemeroff [Emory], Mark Rapaport [Cedars-Sinai], and six Janssen authors presented this Risperdal augmentation in […]
Academic Medicine Deploys a Logical Fallacy to Avoid Disclosing Inconvenient Truths Healthcare Renewal by Dr. Roy Poses September 14, 2011 We recently discussed a simultaneous retreat from aggressive regulation and enforcement applied to big health care corporations by US government agencies. Now a story published by Bloomberg [currently available without a subscription here on PharmaGossip] […]
Two weeks ago, I reported on the case of chicken little…, an eight year old girl whose fear that the "sky was falling" turned out to be related to her reaction to a close call tornado scare some five months earlier. I mentioned that I had gotten a note that she was much improved a […]
The use of such medication as a preventative therapy is controversial because there is no certainty that patients at risk of developing the psychosis will go on to develop the disease. Many patients fail to respond to these medications or only to a limited degree. None of these available medicines reliably produce a complete remission […]
I think there are all kinds of people around out there who have been as bothered with what’s gone on in psychiatry as I have, but have been quiet – the particular thing didn’t by itself rise to the level of alarm, or they were too busy with other matters, or maybe discouraged by the […]
As long as we’re on the subject of psychiatrists working behind the scenes, I’d like to return to the topic of Dr. Patrick McGorry who is in the center of the push for early intervention in an "ultra high risk" of adolescents and young adults who go on to develop Schizophrenia at a greater rate […]
I thought I could just post the Paul Thacker piece in Forbes about Dr. Nemeroff and let it lie, but I made the mistake of reading it again, and it just felt too important to simply link and move on: How An Ethically Challenged Researcher Found A Home at the University of Miami Forbes by […]
I wrote that last post [that track record…] last night after a long clinic day. I guess I’m afraid that people will forget the Nemeroff saga – because they have in the past. After he was busted internally at Emory for unreported drug company income in 2004, Emory forgot. After he was fired as editor […]
Just How Close Was Nemeroff With Glaxo? Pharmalot By Ed Silverman September 13, 2011 … To be specific, in June 2004, an attorney named Greg Martin wrote Nemeroff to ask if he would consult on some planned litigation concerning the likelihood that the Paxil antidepressant might lead some adolescents to attempt or commit suicide. The […]